Pacira Biosciences, Inc. (PCRX)
24.34
+0.38
(+1.59%)
USD |
NASDAQ |
Jun 25, 16:00
24.34
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Cash and Short Term Investments (Quarterly) : 202.18M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 202.18M |
| December 31, 2025 | 238.42M |
| September 30, 2025 | 246.33M |
| June 30, 2025 | 445.86M |
| March 31, 2025 | 493.63M |
| December 31, 2024 | 484.62M |
| September 30, 2024 | 453.81M |
| June 30, 2024 | 404.23M |
| March 31, 2024 | 325.89M |
| December 31, 2023 | 278.58M |
| September 30, 2023 | 235.19M |
| June 30, 2023 | 220.77M |
| March 31, 2023 | 174.00M |
| December 31, 2022 | 288.65M |
| September 30, 2022 | 328.72M |
| June 30, 2022 | 316.39M |
| March 31, 2022 | 452.19M |
| December 31, 2021 | 656.41M |
| September 30, 2021 | 693.86M |
| June 30, 2021 | 646.60M |
| March 31, 2021 | 590.06M |
| December 31, 2020 | 521.66M |
| September 30, 2020 | 532.12M |
| June 30, 2020 | 326.79M |
| March 31, 2020 | 318.46M |
| Date | Value |
|---|---|
| December 31, 2019 | 291.95M |
| September 30, 2019 | 265.64M |
| June 30, 2019 | 292.24M |
| March 31, 2019 | 412.44M |
| December 31, 2018 | 383.45M |
| September 30, 2018 | 386.41M |
| June 30, 2018 | 371.32M |
| March 31, 2018 | 339.79M |
| December 31, 2017 | 311.35M |
| September 30, 2017 | 294.08M |
| June 30, 2017 | 382.44M |
| March 31, 2017 | 383.70M |
| December 31, 2016 | 172.60M |
| September 30, 2016 | 161.13M |
| June 30, 2016 | 162.67M |
| March 31, 2016 | 150.02M |
| December 31, 2015 | 158.96M |
| September 30, 2015 | 146.44M |
| June 30, 2015 | 153.15M |
| March 31, 2015 | 154.89M |
| December 31, 2014 | 158.17M |
| September 30, 2014 | 151.56M |
| June 30, 2014 | 166.03M |
| March 31, 2014 | 64.57M |
| December 31, 2013 | 73.78M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 338.18M |
| Bristol Myers Squibb Co. | 10.49B |
| ANI Pharmaceuticals, Inc. | 326.10M |
| Assertio Holdings, Inc. | 71.57M |
| Veru, Inc. | 30.76M |